Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Universal Corporation (UCL), a Kenyan manufacturer of pharmaceuticals, has secured the certification from World Health Organization (WHO) which will pave way for its entry into the global drugs market.
Subscribe to our email newsletter
The company’s anti-retroviral drug, Lamozid, has been pre-qualified and included in a list of about 255 drugs approved for the fund which develops and manufactures drugs against malaria, Aids, tuberculosis, and reproductive health, allafrica.com reported.
Following the certification, Kenya has joined South Africa, Egypt and Zimbabwe that have WHO pre-qualified drugs.
At present, UCL exports its medicines to countries including Sierra Leone, Malawi and Mozambique.